IL-4/IL-13 sepecific polypetides and therapeutic uses thereof

Details for Australian Patent Application No. 2005219837 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Karow, Margaret; Fairhurst, Jeanette

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005219837

PCT Pub. Number WO2005/085284

Priority 60/628,343 16.11.04 US; 60/602,139 17.08.04 US; 60/548,541 27.02.04 US

Filing date 25 February 2005

Wipo publication date 15 September 2005

International Classifications

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/085284 Priority application(s): WO2005/085284

23 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005219839-Natural IgM antibodies and inhibitors thereof

2005219836-Amino cyclopropane carboxamide derivatives as bradykinin antagonists